Study shows how ALS-linked mutations disrupt the protein TDP-43 at the atomic level, preventing it from executing its ...

The FDA has missed the date for Coya Therapeutics’ investigational new drug (IND) application, citing a lack of resources and ...

Amyotrophic Lateral Sclerosis (ALS), or Lou Gehrig's disease, can affect the way you move, breathe, eat, and behave.

A recent study has revealed a critical gap in the use of accessibility features among people living with Amyotrophic Lateral ...

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease that affects motor neurons, leading to ...

Neuvivo, Inc., a late-stage biopharmaceutical company developing treatments for neurodegenerative disease, today announced it has gained alignment with the U.S. Food and Drug Administration (FDA) on a ...

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive muscle weakness. A research ...

Patient randomization is nearly complete in Medicinova’s Phase 2b/3 COMBAT-ALS trial testing MN-166 (ibudilast) for the ...

Researchers from Biotiche Drug Discovery Srl and collaborators have discovered that modulating the activity of a specific ...

Answer ALS is backing a Louisiana collaboration aimed at using AI to accelerate drug discovery for ALS and other ...

The substantial expansion of the Wally Seaver High School Invitational over the last decade has opened the floor for ...

Amyotrophic lateral sclerosis (ALS) - which you may know as the disease that affected Stephen Hawking - is a fatal ...